Fig. 2From: Obesity is not associated with progression to end stage renal disease in patients with biopsy-proven glomerular diseasesSurvival curves (a) and cumulative incidence functions (b) of time to death and major adverse renal event (MARE) according to BMI group (1 – BMI < 25 kg/m2, 2 – BMI 25–30 kg/m2, 3 – BMI > 30 kg/m2)Back to article page